Skip to main content
Premium Trial:

Request an Annual Quote

EraGen Gets Nod to Market Five RT-PCR Tests in Canada

NEW YORK (GenomeWeb News) - EraGen Biosciences said today that it has received Health Canada approval to market five quantitative PCR-based in vitro diagnostics in the Canadian market.
Health Canada approved the company’s tests for Bordetella pertussis and B. parapertussis; Enterovirus; influenza types A and B; herpes simplex virus 1 and 2; and cytomegalovirus.
Madison, Wisc.-based EraGen performs the tests on its MultiCode-RTx real-time PCR system, which the company said “simplifies and enhances” real-time PCR through the use of a synthetic base pair, called isoC and isoG.
Irene Hrusovsky, president and chief executive of EraGen, said in a statement that the approvals “reinforce EraGen's commitment to international expansion.”

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.